Researchers find new drug target for lung cancer
Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists at the Salk Institute for Biological Studies.
Cancer
Feb 16, 2012 |
5 / 5 (6) |
0
|
Fighting cancer
(Medical Xpress) -- ‘Hijacking’ cells that normally attack common infections to target cancer instead could offer the body a ready-made army against the killer disease University researchers and ...
Cancer
May 09, 2012 |
5 / 5 (6) |
0
|
Common antifungal drug decreases tumor growth and shows promise as cancer therapy
An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this ...
Cancer
Aug 21, 2012 |
5 / 5 (6) |
0
|
Scientists find Achilles' heel of cancer cells
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arresting growth of cultured ...
Cancer
Nov 05, 2012 |
5 / 5 (6) |
0
|
Compound in grapes, red wine could be key to fighting prostate cancer
Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several beneficial effects on human health, including cardiovascular health and stroke prevention. Now, a University ...
Cancer
Nov 10, 2012 |
5 / 5 (6) |
5
|
New monoclonal antibody developed that can target proteins inside cancer cells
Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer ...
Cancer
Mar 13, 2013 |
5 / 5 (6) |
0
|
Study identifies possible therapy for radiation sickness
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists ...
Cancer
Nov 23, 2011 |
4.8 / 5 (6) |
3
|
New understanding of DNA repair could eventually lead to cancer therapy
A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers.
Cancer
Feb 10, 2012 |
4.8 / 5 (6) |
0
|
Cancerous tumors deliver pro-metastatic information in secreted vesicles
Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called ...
Cancer
May 29, 2012 |
4.8 / 5 (6) |
0
|
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
Research breakthrough could halt melanoma metastasis
In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 ...
Cancer
Nov 14, 2012 |
4.8 / 5 (6) |
0
|
Genetic master controls expose cancers' Achilles' heel
In a surprising finding that helps explain fundamental behaviors of normal and diseased cells, Whitehead Institute scientists have discovered a set of powerful gene regulators dubbed "super-enhancers" that control cell state ...
Cancer
Apr 11, 2013 |
4.8 / 5 (6) |
0
|
New evidence links virus to brain cancer
(Medical Xpress) -- Tilting the scales in an ongoing debate, University of Wisconsin-Madison researchers have found new evidence that human cytomegalovirus (HCMV) is associated with glioblastoma multiforme ...
Cancer
Nov 23, 2011 |
4.5 / 5 (6) |
0
|
Team finds mechanism of one of the most powerful tumor-suppressor proteins, Chd5
A team of cancer researchers at Cold Spring Harbor Laboratory (CSHL) has solved the mystery of how one of the most powerful of the body's natural tumor-suppressing proteins, called Chd5, exerts its beneficial effects.
Cancer
Jan 10, 2013 |
4.5 / 5 (6) |
0
|
Common anti-inflammatory coaxes liver cancer cells to commit suicide
The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.
Cancer
May 16, 2011 |
4.3 / 5 (6) |
0
|
